secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK:        0001513525
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001213900-25-054839
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Adial Pharmaceuticals postpones 2025 Annual Meeting to August 1, 2025
---------------------------------------------------------------------

- Annual Meeting date moved from prior schedule to August 1, 2025; record date remains June 4, 2025.
- Stockholders planning to solicit proxies for non-management director nominees must provide Rule 14a-19 notice by June 26, 2025.
- Meeting time and location to be detailed in amended definitive proxy statement to be filed with the SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1513525/000121390025054839/0001213900-25-054839-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1513525/000121390025054839/ea0245887-8k_adial.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-054839

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer